VKTX
🤔 Speculation arises that Pfizer might acquire Viking Therapeutics following the halt of Pfizer’s own weight-loss drug development.
📈 Viking Therapeutics’ stock price saw an uptick, potentially fueled by these buyout rumors in the market.
💰 The video notes Viking’s significant price drop from previous highs (around $100 down to $22) and mentions a potential acquisition price around $2.5 billion.
@bernardodegarcia:
“Something I would really like to hear would be that Pfizer, sooner or later, ends up happening, ends up buying Viking Therapeutics. What a haircut, from almost $100 to $22. I like you, Viking Therapeutics, I like you right where you are… [Later at 742] We have Viking Therapeutics, look, we were just hearing about it right now. Maybe it’s rising because the market thinks, haha, Pfizer has no choice but to effectively buy Viking Therapeutics for $2.5 billion. Doesn’t seem like a bad price to me.”
Watch the exact part of the video where @bernardodegarcia talks about Viking Therapeutics here:
Watch the video on YouTube
Read more articles analyzing Viking Therapeutics (VKTX) at the following link. VKTX stock.
